Cover Image
Market Research Report
Product code 
982423

Global Dry Eye Syndrome Drugs Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Dry Eye Syndrome Drugs Market 2021-2025
Published: January 12, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Technavio has been monitoring the dry eye syndrome drugs market and it is poised to grow by $ 2.08 bn during 2021-2025 progressing at a CAGR of 7% during the forecast period. Our report on dry eye syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the changing lifestyle and rising cases of diseases contributing to dry eye syndrome and growing geriatric population. In addition, changing lifestyle and rising cases of diseases contributing to dry eye syndrome is anticipated to boost the growth of the market as well.

The dry eye syndrome drugs market analysis includes product segment and geographical landscapes.

Technavio's dry eye syndrome drugs market is segmented as below:

By Product

  • OTC drugs
  • Prescription drugs

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing healthcare expenditure as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on dry eye syndrome drugs market covers the following areas:

  • Dry eye syndrome drugs market sizing
  • Dry eye syndrome drugs market forecast
  • Dry eye syndrome drugs market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dry eye syndrome drugs market vendors that include AbbVie Inc., Akorn Inc., Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Novartis AG, Otsuka Holdings Co. Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd.. Also, the dry eye syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR46644

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • OTC drugs - Market size and forecast 2020-2025
  • Prescription drugs - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor Landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Akorn Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Johnson & Johnson
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: OTC drugs - Market size and forecast 2020-2025 ($ million)
  • 24: OTC drugs - Year-over-year growth 2020-2025 (%)
  • 25: Prescription drugs - Market size and forecast 2020-2025 ($ million)
  • 26: Prescription drugs - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: AbbVie Inc. - Overview
  • 48: AbbVie Inc. - Business segments
  • 49: AbbVie Inc. - Key offerings
  • 50: AbbVie Inc. - Key customers
  • 51: AbbVie Inc. - Segment focus
  • 52: Akorn Inc. - Overview
  • 53: Akorn Inc. - Product and service
  • 54: Akorn Inc. - Key offerings
  • 55: Akorn Inc. - Key customers
  • 56: Akorn Inc. - Segment focus
  • 57: Alcon Inc. - Overview
  • 58: Alcon Inc. - Business segments
  • 59: Alcon Inc. - Key offerings
  • 60: Alcon Inc. - Key customers
  • 61: Alcon Inc. - Segment focus
  • 62: Bausch Health Companies Inc. - Overview
  • 63: Bausch Health Companies Inc. - Business segments
  • 64: Bausch Health Companies Inc. - Key offerings
  • 65: Bausch Health Companies Inc. - Key customers
  • 66: Bausch Health Companies Inc. - Segment focus
  • 67: Johnson & Johnson - Overview
  • 68: Johnson & Johnson - Business segments
  • 69: Johnson & Johnson - Key offerings
  • 70: Johnson & Johnson - Key customers
  • 71: Johnson & Johnson - Segment focus
  • 72: Novartis AG - Overview
  • 73: Novartis AG - Business segments
  • 74: Novartis AG - Key offerings
  • 75: Novartis AG - Key customers
  • 76: Novartis AG - Segment focus
  • 77: Otsuka Holdings Co. Ltd. - Overview
  • 78: Otsuka Holdings Co. Ltd. - Business segments
  • 79: Otsuka Holdings Co. Ltd. - Key offerings
  • 80: Otsuka Holdings Co. Ltd. - Key customers
  • 81: Otsuka Holdings Co. Ltd. - Segment focus
  • 82: Prestige Consumer Healthcare Inc. - Overview
  • 83: Prestige Consumer Healthcare Inc. - Business segments
  • 84: Prestige Consumer Healthcare Inc. - Key offerings
  • 85: Prestige Consumer Healthcare Inc. - Key customers
  • 86: Prestige Consumer Healthcare Inc. - Segment focus
  • 87: Santen Pharmaceutical Co. Ltd. - Overview
  • 88: Santen Pharmaceutical Co. Ltd. - Business segments
  • 89: Santen Pharmaceutical Co. Ltd. - Key offerings
  • 90: Santen Pharmaceutical Co. Ltd. - Key customers
  • 91: Santen Pharmaceutical Co. Ltd. - Segment focus
  • 92: Sun Pharmaceutical Industries Ltd. - Overview
  • 93: Sun Pharmaceutical Industries Ltd. - Business segments
  • 94: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 95: Sun Pharmaceutical Industries Ltd. - Key customers
  • 96: Sun Pharmaceutical Industries Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations